• EU steps closer to generics and biosimilars manufacturing waiver pharmaphorum
    February 28, 2019
    A change to European rules on drug manufacturing that could benefit makers of generics and biosimilars is edging closer, after lawmakers agreed draft legislation that tweaks rules on export and manufacture of drugs that are off-patent outside the EU.
PharmaSources Customer Service